COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,241 Articles (22,733 medRxiv, 8,508 bioRxiv)

Most recent first Previous |  Page 1213: Articles 12121-12130  | Next

No Significant Difference in Viral Load Between Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Groups Infected with SARS-CoV-2 Delta Variant
Acharya, C. B., Schrom, J., Mitchell, A. M., Coil, D. A., Marquez, C., Rojas, S., Wang, C. Y., Liu, J., Pilarowski, G., Solis, L., Georgian, E., Petersen, M., DeRisi, J., Michelmore, R., Havlir, D.
10.1101/2021.09.28.21264262 — Posted: 2021-09-29 Discussion: Onsite
A PTX3/LDH/CRP signature correlates with lung injury CTs scan severity and disease progression in paucisymptomatic COVID-19
Folci, M., Brunetta, E., Lanza, E., Bottazzi, B., Protti, A., Messana, G., Lisi, C., Leone, R., Sironi, M., Generali, E., Rodolfi, S., Sagasta, M., Voza, A., Ciccarelli, M., Garlanda, C., Balzarini, L., Mantovani, A., Cecconi, M., Humanitas COVID-19 Task Force
10.1101/2021.09.29.21264061 — Posted: 2021-09-29
The impact of SARS-CoV-2 vaccination on Alpha and Delta variant transmission
Eyre, D. W., Taylor, D., Purver, M., Chapman, D., Fowler, T., Pouwels, K., Walker, A. S., Peto, T. E.
10.1101/2021.09.28.21264260 — Posted: 2021-09-29 Discussion: Onsite
CovRNN - A recurrent neural network model for predicting outcomes of COVID-19 patients: model development and validation using EHR data
Rasmy, L., Nigo, M., Kannadath, B. S., Xie, Z., Mao, B., Patel, K., Zhou, Y., Zhang, W., Ross, A. M., Xu, H., Zhi, D.
10.1101/2021.09.27.21264121 — Posted: 2021-09-29
Young adults vulnerability to COVID-19 in Brazil: an overview across the country
Souza, F. S. H., Hojo-Souza, N. S., de Oliveira, D. C. R., da Silva, C. M., Guidoni, D. L.
10.1101/2021.09.27.21264086 — Posted: 2021-09-29
Calibrating an SIR model for South Korea COVID-19 infections and predicting vaccination impact
Pae, B.
10.1101/2021.09.27.21264172 — Posted: 2021-09-29
Secondary infections modify the overall course of hospitalized COVID-19 patients: A retrospective study from a network of hospitals across North India
Budhiraja, S., TARAI, B., JAIN, D., AGGARWAL, M., INDRAYAN, A., DAS, P., MISHRA, R. S., BALI, S., MAHAJAN, M., KIRTANI, J., TICKOO, R., SONI, P., NANGIA, V., LALL, A., KISHORE, N., JAIN, A., SINGH, O., SINGH, N., KUMAR, A., SAXENA, P., DEWAN, A., AGGARWAL, R., MEHRA, M., JAIN, M., NAKRA, V., SHARMA, B. D., PANDEY, P., SINGH, Y. P., ARORA, V., JAIN, S., CHHABRA, R., TULI, P., BOOBNA, V., JOSHI, A., AGGARWAL, M., GUPTA, R., ANEJA, P., DHALL, S., ARORA, V., CHUGH, I. M., GARG, S., MITTAL, V., GUPTA, A., JYOTI, B., SHARMA, P., BHASIN, P., JAIN, S., SINGHAL, R. K., BHASIN, A., VARDANI, A., PAL, V., PANDE, D. G., GULATI, T., NAYAR, S., KALRA, S., GARG, M., PANDE, R., BAG, P., GUPTA, A., SHARMA, J., HANDOO, A., BURMAN, P., GUPTA, A. K., CHOUDHARY, P. N., GUPTA, A., GUPTA, P., JOSHI, S., TAYAL, N., GUPTA, M., KHANNA, A., KISHORE, S., SAHAY, S., DANG, R., MISHRA, N., SEKHRI, S., SHRIVASTAVA, R. C., AGRAWAL, M. B., MATHUR, M., BANWARI, A., KHETARPAL, S., PANDOVE, S., BHASIN, D., SINGH, H., MIDHA, D., BHUTANI, A., KAUR, M., SINGH, A., SHARMA, S., SINGLA, K., GUPTA, P., SAGAR, V., DIXIT, A., BAJPAI, R., CHACHRA, V., TYAGI, P., SAXENA, S., UNIYAL, B., BELWAL, S., AIER, I., SINGHAL, M., KHANDURI, A.
10.1101/2021.09.27.21264070 — Posted: 2021-09-29
Methods for Estimation of SARS-CoV-2 Seroprevalence and Reported COVID-19 Cases in U.S. Children, August 2020 - May 2021
Couture, A., Lyons, B. C., Mehrotra, M. L., Sosa, L., Ezike, N., Ahmed, F., Brown, C. M., Yendell, S., Cope, A., Katic, B. J., Azzam, I. A., Dickerson, K., Stone, J., Traxler, L. B., Dunn, J., Davis, L. B., Reed, C., Clarke, K. E., Flannery, B., Charles, M. D.
10.1101/2021.09.26.21263756 — Posted: 2021-09-29
Mutational Signatures as Sensors of Environmental Exposures: Role of Smoking in COVID-19 Vulnerabilities
Kim, Y.-A., Hodzic, E., Saslafsky, A., Wojtowicz, D., Amgalan, B., Przytycka, T. M.
10.1101/2021.09.27.461855 — Posted: 2021-09-28
Milk casein prevents inactivation effect of black tea galloylated theaflavins on SARS-CoV-2 in vitro
Ohgitani, E., Shin-Ya, M., Ichitani, M., Kobayashi, M., Takihara, T., Saito, M., Kinugasa, H., Mazda, O.
10.1101/2021.09.27.461930 — Posted: 2021-09-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).